The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles

Handbook of Experimental Pharmacology

Volumn 180, Issue , 2007, Pages 263-283

  Hall, B ^a   Andreeff, M ^b   Marini, F ^b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Desmoplasia; Mesenchymal Stem Cell (MSC); Myofibroblast; Stromagenesis; Tumor Microenvironment; Tumor Stroma; Tumor associated Fibroblast (TAF)

Indexed keywords

ANIMAL; DISEASE COURSE; GENE THERAPY; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; STROMA CELL; WOUND HEALING;

ANIMALS; DISEASE PROGRESSION; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOPLASMS; STROMAL CELLS; WOUND HEALING;

EID: 34547567884     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-68976-8_12     Document Type: Article

References (138)

1. Allers C, SierraltaWD, Neubauer S, Rivera F,Minguell JJ, Conget PA (2004) Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78:503-508
2. Almeida-Porada G, Porada C, Zanjani ED (2004) Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation. Int J Hematol 79:1-6
3. Baksh D, Song L, Tuan RS (2004) Adultmesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301-316
4. Ballas CB, Zielske SP, Gerson SL (2002) Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 38:20-28
5. Bang OY, Lee JS, Lee PH, Lee G (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874-882
6. Barcellos-Hoff MH, Ravani SA (2000) Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60:1254-1260
7. Bianchi G, Muraglia A, Daga A, Corte G, Cancedda R, Quarto R (2001) Microenvironment and stem properties of bone marrow-derived mesenchymal cells. Wound Repair Regen 9:460-466
8. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7:17-23
9. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46-54
10. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M (2005) Tumorigenic heterogeneity in cancer stem cells evolved fromlong-termcultures of telomeraseimmortalized human mesenchymal stem cells. Cancer Res 65:3126-3135
11. Burns MJ, Weiss W (2003) Targeted therapy of brain tumors utilizing neural stem and progenitor cells. Front Biosci 8:e228-234
12. Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264
13. Chan J, ODonoghue K, de la Fuente J, et al (2005) Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23:93-102
14. Chen J, Wang C, Lu S, et al (2005) In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res 319:429-438
15. Chen SL, Fang WW, Ye F, et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95
16. Chung LW, Baseman A, Assikis V, Zhau HE (2005) Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 173:10-20
17. Coussens LM,Werb Z (2002) Inflammation and cancer. Nature 420:860-867
18. Cunha GR,HomYK (1996) Role of mesenchymal-epithelial interactions inmammary gland development. J Mammary Gland Biol Neoplasia 1:21-35
19. Cunha GR, Hayward SW,Wang YZ, RickeWA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107:1-10
20. Dai W, Hale SL, Martin BJ, et al (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112:214-223
21. De Kok IJ, Drapeau SJ, Young R, Cooper LF (2005) Evaluation of mesenchymal stem cells following implantation in alveolar sockets: a canine safety study. Int J Oral Maxillofac Implants 20:511-518
22. De Palma M, Venneri MA, Roca C, Naldini L (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9:789-795
23. De Palma M, Venneri MA, Galli R, et al (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211-226
24. DeWever O,MareelM(2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447
25. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884
26. Dennis JE, Cohen N, Goldberg VM, Caplan AI (2004) Targeted delivery of progenitor cells for cartilage repair. J Orthop Res 22:735-741
27. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R (2003) Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999-3001
28. Direkze NC, Forbes SJ, Brittan M, et al (2003)Multiple organ engraftment by bone-marrowderived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 21:514-520
29. Direkze NC, Hodivala-Dilke K, Jeffery R, et al (2004) Bone marrow contribution to tumorassociated myofibroblasts and fibroblasts. Cancer Res 64:8492-8495
30. Djouad F, Plence P, Bony C, et al (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844
31. Dong J, Grunstein J, Tejada M, et al (2004) VEGF-null cells require PDGFR alpha signalingmediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800-2810
32. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659
33. Emura M, Ochiai A, Horino M, Arndt W, Kamino K, Hirohashi S (2000) Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev Biol Anim 36:77-80
34. Erices AA, Allers CI, Conget PA, Rojas CV, Minguell JJ (2003) Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant 12:555-561
35. Evans CH, Robbins PD, Ghivizzani SC, et al (2005) Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A 102:8698-8703
36. Feldmann RE Jr, Bieback K, Maurer MH, et al (2005) Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis 26:2749-2758
37. Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990-998
38. Fierro FA, SierraltaWD, Epunan MJ,Minguell JJ (2004)Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 21:313-319
39. Folkman J (2003) Fundamental concepts of the angiogenic process. CurrMolMed 3:643-651
40. Folkman J (2004) Endogenous angiogenesis inhibitors. Apmis 112:496-507
41. Forbes SJ, Russo FP, Rey V, et al (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126:955-963
42. Forte G, Minieri M, Cossa P, et al (2006) Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24:23-33
43. Fukuda K (2003)Use of adult marrowmesenchymal stemcells for regeneration of cardiomyocytes. Bone Marrow Transplant 32 [Suppl 1]:S25-27
44. Gallego MI, Binart N, Robinson GW, et al (2001) Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 229:163-175
45. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohns fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416-1423
46. Gojo S, Umezawa A (2003) Plasticity of mesenchymal stem cells-regenerative medicine for diseased hearts. Hum Cell 16:23-30
47. Gronthos S, Zannettino AC, Hay SJ, et al (2003) Molecular and cellular characterisation of highly purified stromal stemcells derived fromhuman bone marrow. J Cell Sci 116:1827-1835
48. Haffen K, Kedinger M, Simon-Assmann P (1987) Mesenchyme-dependent differentiation of epithelial progenitor cells in the gut. J Pediatr Gastroenterol Nutr 6:14-23
49. Hamada H, Kobune M, Nakamura K, et al (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96:149-156
50. Hanahan D,Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
51. Harrington K, Alvarez-Vallina L, Crittenden M, et al (2002) Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther 13:1263-1280
52. Hasebe T, Mukai K, Tsuda H, Ochiai A (2000) New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int 50:263-272
53. Hill R, Song Y, Cardiff RD, Van Dyke T (2005) Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123:1001-1011
54. Hombauer H, Minguell JJ (2000) Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 82:1290-1296
55. Honma T, Honmou O, Iihoshi S, et al (2006) Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 199:56-66
56. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313
57. Houghton J, Stoicov C,Nomura S, et al (2004) Gastric cancer originating frombone marrowderived cells. Science 306:1568-1571
58. Hurwitz DR, Kirchgesser M, Merrill W, et al (1997) Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 8:137-156
59. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE (2002) The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 62:5351-5357
60. In t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338-1345
61. Ishii G, Sangai T, Oda T, et al (2003) Bone-marrow-derivedmyofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 309:232-240
62. Ishii G, Sangai T, Ito T, et al (2005) In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma. Int J Cancer 117:212-220
63. JankowskiK,KuciaM,WysoczynskiM,et al (2003)Both hepatocyte growth factor(HGF)and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but onlyHGF enhances their resistance to radiochemotherapy. CancerRes 63:7926-7935
64. Jiang H, Conrad C, Fueyo J, Gomez-Manzano C, Liu TJ (2003) Oncolytic adenoviruses for malignant glioma therapy. Front Biosci 8:d577-588
65. Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J (2006) Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 66:2146-2152
66. Kammertoens T, Schuler T, Blankenstein T (2005) Immunotherapy: target the stroma to hit the tumor. Trends Mol Med 11:225-231
67. Kan I,Melamed E, Offen D (2005) Integral therapeutic potential of bone marrow mesenchymal stem cells. Curr Drug Targets 6:31-41
68. Kaplan RN, Riba RD, Zacharoulis S, et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827
69. Kassem M (2004) Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 6:369-374
70. Kenny PA, BissellMJ (2003) Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 107:688-695
71. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A, Kalofoutis A (2005) Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65:1627-1630
72. Koc ON, Day J,Nieder M, Gerson SL, Lazarus HM, KrivitW(2002) Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215-222
73. Kraitchman DL, Tatsumi M, Gilson WD, et al (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112:1451-1461
74. Kunz-Schughart LA, Knuechel R (2002a) Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol 17:599-621
75. Kunz-Schughart LA, Knuechel R (2002b) Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol Histopathol 17:623-637
76. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S,Watson PH, Eng C (2001) Genetic model ofmulti-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 10:1907-1913
77. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C (2002) Frequent somatic mutations in PTEN and TP53 aremutually exclusive in the stroma of breast carcinomas. Nat Genet 32:355-357
78. KurosumiM,TabeiT, Inoue K, et al (2003)Prognostic significance of scoring systembased on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients. Oncol Rep 10:833-837
79. Kurozumi K, Nakamura K, Tamiya T, et al (2004) BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9:189-197
80. Kurozumi K, Nakamura K, Tamiya T, et al (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11:96-104
81. Lange C,Togel F, Ittrich H, et al (2005)Administered mesenchymal stemcells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613-1617
82. Lazarus HM, Koc ON, Devine SM, et al (2005) Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398
83. Le Blanc K, PittengerM(2005)Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36-45
84. Le Blanc K,RasmussonI, SundbergB, et al (2004)Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441
85. Mansilla E, Marin GH, Sturla F, et al (2005) Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplant Proc 37:292-294
86. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555
87. McCullough KD, Coleman WB, Ricketts SL, Wilson JW, Smith GJ, Grisham JW (1998) Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc Natl Acad Sci U S A 95:15333-15338
88. McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ (2004) Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6:311-317
89. Mintz B, Illmensee K (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 72:3585-3589
90. Moinfar F,Man YG, Arnould L, Bratthauer GL, RatschekM, Tavassoli FA (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60:2562-2566
91. Mueller MM, Fusenig NE (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839-849
92. Nakamizo A, Marini F, Amano T, et al (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318
93. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S, Yasunaga Y (2004) Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng 10:1093-1112
94. Ohlsson LB, Varas L, Kjellman C, Edvardsen K, LindvallM(2003)Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatinmatrix. ExpMol Pathol 75:248-255
95. Orimo A, Gupta PB, Sgroi DC, et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF- 1/CXCL12 secretion. Cell 121:335-348
96. Ortiz LA, Gambelli F, McBride C, et al (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:8407-8411
97. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14:506-514
98. Philip M, Rowley DA, Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14:433-439
99. Phinney DG, Isakova I (2005) Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 11:1255-1265
100. Pittenger MF, Mackay AM, Beck SC, et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
101. Polverini PJ, Leibovich SJ (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51:635-642
102. Prindull G, Zipori D (2004) Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 103:2892-2899
103. Prockop DJ (1997)Marrow stromal cells as stemcells for nonhematopoietic tissues. Science 276:71-74
104. Prockop DJ, Sekiya I, Colter DC (2001) Isolation and characterization of rapidly selfrenewing stemcells fromculturesofhumanmarrowstromalcells.Cytotherapy 3:393-396
105. Radisky DC, Levy DD, Littlepage LE, et al (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436:123-127
106. ReyesM, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM(2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625
107. Richter G, Kruger-Krasagakes S,Hein G, et al (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 53:4134-4137
108. Robinson SC, Coussens LM (2005) Soluble mediators of inflammation during tumor development. Adv Cancer Res 93:159-187
109. Rojas M, Xu J, Woods CR, et al (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145-152
110. Roni V, HabelerW, Parenti A, et al (2003) Recruitment of human umbilical vein endothelial cells and human primary fibroblasts into experimental tumors growing in SCID mice. Exp Cell Res 287:28-38
111. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ (1995) The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95:859-873
112. Ronnov-Jessen L, Petersen OW, BissellMJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76:69-125
113. Rowley DR (1998) What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 17:411-419
114. Rubio D, Garcia-Castro J, Martin MC, et al (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039
115. Sakakura T, Nishizuka Y, Dawe CJ (1976) Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. Science 194:1439-1441
116. Sangai T, Ishii G, Kodama K, et al (2005) Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells andmyofibroblasts in cancer-induced stroma. Int J Cancer 115:885-892
117. Sato Y, Araki H, Kato J, et al (2005) Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106:756-763
118. Satoh H, Kishi K, Tanaka T, et al (2004) Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds. Cell Transplant 13:405-412
119. Schoeberlein A, HolzgreveW, Dudler L, Hahn S, Surbek DV (2005) Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses. Am J Obstet Gynecol 192:1044-1052
120. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530-541
121. Serakinci N, Guldberg P, Burns JS, et al (2004) Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23:5095-5098
122. Silva GV, Litovsky S, Assad JA, et al (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150-156
123. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, Kunz-Schughart LA (2003) Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 33:1311-1320
124. Silzle T, Randolph GJ, KreutzM, Kunz-Schughart LA (2004) The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 108:173-180
125. Sivridis E, GiatromanolakiA,KoukourakisMI(2005)Proliferatingfibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol 58:1033-1038
126. SternlichtMD, Lochter A, Sympson CJ, et al (1999) The stromal proteinase MMP3/stromelysin- 1 promotes mammary carcinogenesis. Cell 98:137-146
127. Sternlicht MD, Bissell MJ, Werb Z (2000) The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19:1102-1113
128. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603-3608
129. Studeny M, Marini FC, Dembinski JL, et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593-1603
130. Sugimoto T, TakiguchiY,Kurosu K, et al (2005)Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer. Oncol Rep 14:823-830
131. Tlsty TD, Hein PW (2001) Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11:54-59
132. Wiesen JF, Young P, Werb Z, Cunha GR (1999) Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126:335-344
133. Wright N, de Lera TL, Garcia-Moruja C, et al (2003) Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 102:1978-1984
134. Xia Z, Ye H, Choong C, et al (2004) Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice. J Biomed Mater Res A 71:538-548
135. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65:8887-8895
136. Ye J, Yao K, Kim JC (2006) Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye 20:482-490
137. Yoneda T, Hiraga T (2005) Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328:679-687
138. ZhuW, XuW, Jiang R, et al (2006)Mesenchymal stem cells derived frombone marrow favor tumor cell growth in vivo. Exp Mol Pathol 80:267-274